Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Black Box Warning: Spinal/epidural hematoma risk
Search results for:
HEPARIN
HEPARIN
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| HEPARIN 25,000 UNITS IN 250 ML D5W | GENESIS STANDARD CONCENTRATION | 100 UNITS/ML | ||
| HEP-LOCK | INJECTION | 10 u/ml | ||
| HEPARIN LOCK FLUSH | INJECTION | 10 u/ml | ||
| HEPARIN LOCK FLUSH | INJECTION | 100 u/ml | ||
| HEPARIN SODIUM | INJECTION | 1000 u/ml | ||
| HEPARIN SODIUM | INJECTION | 2500 u/ml | ||
| HEPARIN SODIUM | INJECTION | 5000 u/ml | ||
| HEPARIN SODIUM | INJECTION | 20000 u/ml | ||
| HEPARIN 25,000 UNITS IN 250 ML 0.45% NACL | INJECTION, SOLUTION |
View Other Therapeutic Options: Antithrombotic Agents, Anticoagulants, Heparins:
201200, 201204, 20120416
High Alert Drug
Last updated: Nov. 22, 2023
- Drug Administration Guidelines Drug Administration Guidelines
- Black Box Warning: Spinal/epidural hematoma risk
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.
New Heparin Anti-Xa Protocol launches Tuesday, April 25th. The following are important forms needed for dosing, weight adjustments, and educational resources:
Adult Unfractionated Heparin Anti-Xa Protocol
Initial Starting Heparin Drip Rates Based on Weight
Anti-Xa Education Teach Tool for Pharmacists
PTT monitoring will still be used under specific circumstances (see Anti-Xa Policy)
Full GHS Policy for Management of Anticoagulants including REVERSAL (Appendix B) and dosing:
Anticoagulant Management Program Reviewed 04/15/23